Related Experiment Videos
Improving person-centred care in dementia
Dorothy Armstrong1, Grainne Byrne
1Scottish Public Services Ombudsman.
Nursing Times
|December 31, 2011
Summary
Nurses can improve dementia care in hospitals. This article provides essential knowledge and resources for delivering compassionate, person-centred care to patients with dementia.
Area of Science:
- Gerontology
- Nursing Science
- Healthcare Quality
Background:
- Reports indicate significant failings in dementia care within acute hospital settings across Scotland and the UK.
- Concerns have been raised by bodies such as the Scottish Public Services Ombudsman, highlighting the need for improved care standards.
Purpose of the Study:
- To equip nurses with essential knowledge and resources for providing high-quality dementia care.
- To promote compassionate and person-centred care approaches for individuals with dementia in acute hospital environments.
Main Methods:
- This article synthesizes existing knowledge and identifies relevant resources.
- It focuses on practical information applicable to nursing practice.
Main Results:
- Key knowledge areas for effective dementia care are outlined.
- A curated list of resources is provided to support nurses.
Conclusions:
- Nurses require specific knowledge and resources to address the complexities of dementia care in hospitals.
- Implementing person-centred and compassionate care is crucial for improving patient outcomes and experiences.
Related Concept Videos
01:13Patient-centered Care
Patient-centered care involves delivering care beyond inpatient hospitalization. Reflective practice can enhance a patient-centered approach. Reflective practice is a process of reasoning that considers all aspects of the present situation, including practicalities, learning from personal practice, and consideration of patient needs. Patients appreciate care decisions made while considering their input. Involving the patient in their care provides the patient with a sense of contribution rather...
01:29Documentation in Long-Term and Home Healthcare Setting
Documentation in long-term care facilities and home healthcare settings is crucial for ensuring continuous, coordinated, and comprehensive care for patients. Each setting has its specific documentation processes and tools:
Long-Term Care Facilities
Long-Term Care Facilities
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
01:30Dementia
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
The progression of dementia is generally gradual.
01:27Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
01:22Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...